Ki Tae Suk

机构：Hallym University, Sacred Heart Hospital, Center for Digestive and Liver Diseases, Hallym University Medical Center · ORCID：0000-0002-9206-9245

发表论文 367 篇 · 总被引 8824 次 · h-index 50

代表论文

• Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation (2025 · Gut Microbes · 被引 15)
• The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial (2025 · Journal of Translational Medicine · 被引 7)
• Gut Microbiome-Based Strategies for the Control of Carbapenem-Resistant Enterobacteriaceae (2025 · Journal of Microbiology and Biotechnology · 被引 5)
• The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma (2025 · Critical Reviews in Microbiology · 被引 4)
• Probiotic-Derived Strain-Specific Metabolites Ameliorate Metabolic Dysfunction–Associated Steatotic Liver Disease through Modulation of the Gut-Liver Axis (2025 · Probiotics and Antimicrobial Proteins · 被引 3)
• A roadmap to unveil the mechanism(s) of natural indole-derived molecules against NAFLD-derived HCC via systems pharmacology (2025 · Translational Oncology · 被引 2)